← Open Payments lookup

LISA O'DONNAL: Open Payments

NPI 1124584867 · RICHFIELD, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,554 in 74 payments from 14 companies in 2025. Trend: 2023 $935 · 2024 $1,765 · 2025 $1,554

Food & beverage: $1,550Education: $4
CompanyPaymentsAmount
ABBVIE INC.11$253
Teva Pharmaceuticals USA, Inc.17$238
Alkermes, Inc.10$206
Neurocrine BioSciences, Inc.10$196
Otsuka America Pharmaceutical, Inc.4$180
Braeburn Inc.3$101
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$90
Axsome Therapeutics, Inc.4$84
Vanda Pharmaceuticals Inc.3$83
Supernus Pharmaceuticals, Inc.2$36

Products named: VRAYLAR, AUSTEDO XR, INGREZZA, REXULTI, ARISTADA, BRIXADI, LYBALVI, CAPLYTA.

Industry payments across UT — which companies pay providers there.